Kevin Hou

MolAIcule, Inc.

BIOGRAPHY

Kevin Hou is the Co-founder and Chief Executive Officer of MolAIcule, Inc., where he leads the development of an AI-driven drug discovery platform integrating design–make–test–learn cycles to accelerate peptide therapeutics. His work focuses on foldamers and peptidomimetics, optimizing candidates for function, stability, and bioavailability.

Kevin has over 20 years of experience building machine learning and AI systems across industries. At MolAIcule, he combines deep scientific insights with advanced computational methods to transform early-stage drug discovery.